Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
复制标题
DOI：
10.3322/caac.21660
复制
发表时间：
2021-02-04
影响因子：
254.7
通讯作者：
Bray, Freddie
中科院分区：
文献类型：
--
作者：
Sung, Hyuna;Ferlay, Jacques;Bray, Freddie
本文使用国际癌症研究机构编制的GLOBOCAN 2020癌症发病率和死亡率估计，提供了全球癌症负担的最新情况。在全球范围内，2020年估计发生了1930万新癌症病例(不包括非黑色素瘤皮肤癌)和近1000万癌症死亡(不包括非黑色素瘤皮肤癌)。女性乳腺癌已超过肺癌成为最常见的诊断癌症，估计有230万新病例(11.7%)，其次是肺癌(11.4%)、结直肠癌(10.0%)、前列腺癌(7.3%)和胃癌(5.6%)。肺癌仍然是癌症死亡的主要原因，估计有180万人死亡(18%)，其次是结直肠癌(9.4%)、肝癌(8.3%)、胃癌(7.7%)和女性乳腺癌(6.9%)。转型国家的总体发病率是转型国家的2倍至3倍，而死亡率则各不相同。
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied